8SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934
Filed by the Registrant [X]
Filed by a Party other than the Registrant [_]
Check the appropriate box:
[_] Preliminary Proxy Statement
[_] Confidential, for Use of the Commission Only (as permitted by Rule
14a-6(e)(2))
[_] Definitive Proxy Statement
[X] Definitive Additional Materials
[X] Soliciting Material Pursuant to Section 240.14a-12
DELCATH SYSTEMS, INC.
(Name of Registrant as Specified In Its Charter)
-----------------------------------------
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
[X] No fee required.
[_] Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
(1) Title of each class of securities to which transaction applies:
-------------------------------------------------
(2) Aggregate number of securities to whichtransaction applies:
-------------------------------------------------
(3) Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (set forth the amount on which the
filing fee is calculated and state how it was determined):
-------------------------------------------------
(4) Proposed maximum aggregate value of transaction:
-------------------------------------------------
(5) Total fee paid:
-------------------------------------------------
[_] Fee paid previously with preliminary materials.
[_] Check box if any part of the fee is offset as provided by Exchange Act Rule
0-11(a)(2) and identify the filing for which the offsetting fee was paid
previously. Identify the previous filing by registration statement number, or
the Form or Schedule and the date of its filing.
(1) Amount Previously Paid:
-------------------------------------------------
(2) Form, Schedule or Registration Statement No.:
-------------------------------------------------
(3) Filing Party:
-------------------------------------------------
(4) Date Filed:
-------------------------------------------------
[GRAPHIC OMITTED]
Company Contact: Investor Contacts:
Delcath Systems, Inc. Todd Fromer / Garth Russell
M. S. Koly, Chief Executive Officer KCSA Worldwide
203-323-8668 (212) 896-1215 / (212) 896-1250
www.delcath.com tfromer@kcsa.com / grussell@kcsa.com
--------------- ---------------- -----------------
Media Contact:
Lewis Goldberg
KCSA Worldwide
(212) 896-1216
lgoldberg@kcsa.com FOR IMMEDIATE RELEASE
------------------
Delcath Systems to Host a Special "Town Hall" Meeting
with Shareholders in Stamford, CT
- - -
STAMFORD, Conn., August 25, 2006 -- Delcath Systems, Inc. (NASDAQ: DCTH)
announced today that it will host a special "Town Hall" meeting with Delcath
shareholders at 10:00 am ET on Friday, September 8, 2006 at the Sheraton in
Stamford, CT. This event will provide Delcath shareholders with an opportunity
to ask questions of Delcath's President and Chief Executive Officer, Mr. M.S.
Koly, regarding Delcath's current and future business and its ongoing defense of
the attempted hostile takeover of the Company by Laddcap Value Partners, LP.
This event will be open to all Delcath shareholders who register with the
Company in advance of the meeting. The event also will be webcast live over the
Internet at the Company's website. Shareholders who wish to listen to the
webcast should visit www.delcath.com and click on the "Town Hall Meeting" link
15 minutes before the start of the meeting. Delcath encourages all shareholders
who are unable to attend the meeting in person to take advantage of the live
webcast. An archive of the webcast will be available for 30 days following the
meeting on the Company's website.
Mr. Koly said, "This is a critical time for Delcath and its shareholders. We
believe it is important for our shareholders to clearly understand the current
management and Board's strategic plan for Delcath, as well as our serious
concerns regarding Laddcap's attempt to seize control of the Company. We will be
taking this opportunity to allow shareholders to directly ask management
questions about the future of the Company. We encourage all shareholders, who
are able, to attend in person."
Registration Information:
-------------------------
Shareholders who wish to attend must register in advance by contacting Todd
Fromer or Garth Russell, of KCSA Worldwide, at 212-896-1215 or 212-896-1250.
Only record or beneficial owners of Delcath's Common Stock may attend the Town
Hall Meeting in person. When you arrive at the Town Hall Meeting, you must
present photo identification, such as a driver's license. Beneficial
owners must also provide evidence of stock holdings, such as a recent brokerage
account or bank statement.
About Delcath Systems, Inc.
Delcath Systems is a developer of isolated perfusion technology for organ or
region-specific delivery of therapeutic agents. The Company's intellectual
property portfolio currently consists of 12 patents on a worldwide basis,
including the United States, Europe, Asia and Canada. For more information,
please visit the Company's website, www.delcath.com.
This release contains forward-looking statements, which are subject to certain
risks and uncertainties that can cause actual results to differ materially from
those described. Factors that may cause such differences include, but are not
limited to, uncertainties relating to our ability to successfully complete Phase
III clinical trials and secure regulatory approval of our current or future
drug-delivery system and uncertainties regarding our ability to obtain financial
and other resources for any research, development and commercialization
activities. These factors, and others, are discussed from time to time in our
filings with the Securities and Exchange Commission. You should not place undue
reliance on these forward-looking statements, which speak only as of the date
they are made. Delcath undertakes no obligation to publicly update or revise
these forward-looking statements to reflect events or circumstances after the
date they are made.
On August 17, 2006, Laddcap filed a definitive consent solicitation statement
with the SEC relating to Laddcap's proposal to, among other things, remove the
current Board of Directors and replace them with Laddcap's nominees. In
response, on August 21, 2006, Delcath filed a definitive consent revocation
statement on Form DEFC14A (the "Definitive Consent Revocation Statement") with
the SEC in opposition to Laddcap's consent solicitation. Delcath shareholders
should read the Definitive Consent Revocation Statement (including any
amendments or supplements thereto) because it contains additional information
important to the shareholders' interests in Laddcap's consent solicitation.
The Definitive Consent Revocation Statement and other public filings made by
Delcath with the SEC are available free of charge at the SEC's website at
www.sec.gov. Delcath also will provide a copy of these materials free of charge
upon request to Delcath Systems, Inc., Attention: M.S. Koly, President and Chief
Executive Officer, (203) 323-8668.
# # #